Sign in

NCT05803343Recruiting

Evaluating Additive Effects of Including Canines in Regulating Together

Evaluating Additive Effects of Including Canines in Regulating Together: A Group Treatment to Address Emotion Dysregulation in Youth With Autism Spectrum Disorder

Source: ClinicalTrials.gov · Last updated 8 Jul 2026

Brief summary (registry, in English)

The primary objective is to evaluate the potential additive effect of animal-assisted intervention (AAI) on a manualized behavioral treatment targeting emotion dysregulation (ED) in children with autism spectrum disorder (ASD). Aim 1: Evaluate whether Regulating Together-Canine demonstrates earlier and greater improvement in emotion dysregulation than Regulating Together-Standard. Aim 2: Evaluate if Regulating Together-Canine increases child engagement and learning compared to Regulating Together-Standard. Exploratory Aim: Explore association of physiological arousal (via heart rate tracking) with emotion dysregulation, treatment engagement, and learning.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
240 (estimated)
First submitted
15 Mar 2023
Start date
28 Feb 2023
Primary completion date
21 Jan 2028
Lead sponsor
Children's Hospital Medical Center, Cincinnati
Diseases
Autism
NCT number
NCT05803343

What you commit to

  • Study type: Interventional
  • Planned participants: 240
  • From 28 Feb 2023 to the primary completion date, 21 Jan 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Participant has a phobia toward or is allergic to canines
  • Participant has a history of aggression toward animals
  • Presence of comorbid major neuropsychiatric illness warranting other treatment approaches as determined by the study clinician(s) including substance use disorders, psychotic disorders/schizophrenia, and bipolar disorder, among others
  • Presence of any major sensory impairment that would limit participating in the material including blindness or uncorrected hearing loss

Other

  • Participant has had any physical aggression toward other children outside the home in the past 2 weeks that resulted in injury
  • A legal guardian is not available to provide informed consent

Who the study is looking for

  • Concern of emotion dysregulation (ED) as measured by a score of 6 or greater on the Emotion Dysregulation Inventory-Reactivity (EDI-R)
  • Diagnosis of autism spectrum disorder (ASD)
  • Diagnosis confirmed by an experienced ASD clinician and further supported by scoring in the range for ASD on the Autism Diagnostic Observation Schedule (ADOS-2)
  • A Full Scale Intelligence Quotient score of 65 or greater on the Weschler Abbreviated Scale Intelligence (WASI-II)
  • English is the primary language
  • Family willing to keep prescribed medication stable over the course of the study period

Age in the registry: 8 years to 15 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
Cincinnati Children's Hospital Medical Center
Coordinator of this site? Confirm its status
CincinnatiUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.